Merck's Keytruda fails pivotal gastric cancer trial

(Reuters) - Merck & Co Inc said on Thursday a key late-stage trial testing its blockbuster drug, Keytruda, failed to meet its main goal of extending lives of patients with a type of gastric cancer.

from Reuters: Health News http://reut.rs/2Cpg07k